The U.S. Food and Drug Administration has issued a report [PDF | 293KB] on how the agency communicates the benefits and risks of medical products to health care providers and patients, especially underrepresented populations, including racial subgroups.
FDA has opened a docket to seek public comment on the report's findings and FDA's communication plans going forward.
Please submit electronic or written comments by September 9, 2013.
For more information click the language links below:
In English , 中文 (Chinese), Français (French), Español (Spanish), Tagalog (Tagalog), and Việt (Vietnamese)
For further information contact:
omh@fda.hhs.gov
Office of Minority Health
US Food & Drug Administration
White Oak Campus
10903 New Hampshire Avenue
Silver Spring, MD 20993
No comments:
Post a Comment